WEREWOLF THERAPEUTICS, INC. Shareholders' Equity
WEREWOLF THERAPEUTICS, INC. (HOWL) had Shareholders' Equity of $16.29 million as of 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-22
- 2026-06-30: Stockholders' Equity Attributable to Parent $16.29M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $12.20M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $24.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $29.61M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $16.29M S-4 · filed 2026-09-22 |
| 2026-03-31 | $12.20M S-4 · filed 2026-09-22 |
| 2025-12-31 | $24.80M S-4 · filed 2026-09-22 |
| 2025-09-30 | $29.61M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $41.46M S-4 · filed 2026-09-22 |
| 2025-03-31 | $57.31M S-4 · filed 2026-09-22 |
| 2024-12-31 | $73.39M S-4 · filed 2026-09-22 |
| 2024-09-30 | $89.38M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $104.02M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $117.59M 10-Q · filed 2025-11-04 |
| 2023-12-31 | $111.37M S-4 · filed 2026-09-22 |
| 2023-09-30 | $112.44M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $118.60M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $121.07M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $122.34M 10-K · filed 2025-03-11 |
| 2022-09-30 | $130.95M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $129.84M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $139.32M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $152.79M 10-K · filed 2024-03-07 |
| 2021-09-30 | $169.30M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $181.56M 10-Q · filed 2022-11-10 |
| 2021-03-31 | -$153.75M 10-Q · filed 2022-11-10 |
| 2020-12-31 | -$51.86M 10-K · filed 2023-03-23 |
| 2020-09-30 | -$31.56M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$25.63M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$28.07M 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$24.30M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |